Multiple sclerosis flare secondary to COVID-19 vaccine, a case report
- ahmad matarneh,
- Alia Al Battah,
- Riyadh Hammamy,
- Mohammed alhatou
ahmad matarneh
Hamad medical corporation
Corresponding Author:ahmadmatarneh99@gmail.com
Author ProfileAbstract
We report a 60-year-old lady known to have a stable MS disease. Who
presented with right-hand weakness on the same day of COVID 19 vaccine
administration. MRI showed a relapse, and she was treated with steroids
with improvement in her symptoms. neurological side effects can occur
following COVID 19 vaccines